Yahoo Web Search

Search results

1. • • NASDAQ: HRTX · Real-Time Price · USD 1.850 +0.070 (3.93%) At close: Oct 25, 2024, 4:00 PM 1.840 -0.010 (-0.54%) After-hours: Oct 25, 2024, 7:56 PM EDT
     stockanalysis.com/stocks/hrtx/

     Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News ...

2. People also ask

   Does NASDAQ use Heron Therapeutics (hrtx) stock to determine compliance?

   • NASDAQ does not use this value to determine compliance with the listing requirements. Discover real-time Heron Therapeutics, Inc. Common Stock (HRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

   Heron Therapeutics, Inc. Common Stock - Nasdaq

   www.nasdaq.com/market-activity/stocks/hrtx

   See all results for this question

   What is the 12-month price forecast for heron Therapeutics (hrtx)?

   • The 12-month stock price forecast is $6.0, which is an increase of 226.09% from the latest price. SAN DIEGO , Oct. 10, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today reaffirmed the Company's ability to supply...

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Who is Heron Therapeutics?

   • Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care.

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Should you buy Heron Therapeutics (hrtx) in 2023?

   • In 2023, Heron Therapeutics's revenue was $127.04 million, an increase of 17.99% compared to the previous year's $107.67 million. Losses were -$110.56 million, -39.26% less than in 2022. According to 3 analysts, the average rating for HRTX stock is "Strong Buy."

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Does Heron therapeutics have a conference call?

   • SAN DIEGO , July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webca...

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Does Heron Therapeutics (hrtx) gain FDA nod for new zynrelef application?

   • HRTX News Heron gains on FDA nod for new Zynrelef application SA NewsWed, Sep. 251 Comment Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript SA TranscriptsFri, Aug. 09 Heron Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation SA TranscriptsFri, Aug. 09

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/HRTX

   See all results for this question

3. finance.yahoo.com › quote › HRTXHeron Therapeutics, Inc. (HRTX) Stock Price, News, Quote ...

   finance.yahoo.com › quote › HRTX

   • Cached

   Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

   • Profile

     See the company profile for Heron Therapeutics, Inc. (HRTX)...

   • Options

     View the basic HRTX option chain and compare options of...

   • Financials

     Get the detailed quarterly/annual income statement for Heron...

   • Conversations

     Find the latest Heron Therapeutics, Inc. (HRTX) stock...

   • Holders

     Holder Shares Date Reported % Out Value; Vanguard Total...

   • Analysis

     See Heron Therapeutics, Inc. (HRTX) stock analyst estimates,...

   • Statistics

     Find out all the key statistics for Heron Therapeutics, Inc....

   • Historical Data

     Discover historical prices for HRTX stock on Yahoo Finance....

4. www.google.com › finance › quoteHeron Therapeutics Inc (HRTX) Stock Price & News - Google

   www.google.com › finance › quote

   Get the latest Heron Therapeutics Inc (HRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5. stockanalysis.com › stocks › hrtxHeron Therapeutics, Inc. (HRTX) Stock Price, Quote & News ...

   stockanalysis.com › stocks › hrtx

   • Cached

   Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.

   • Market Cap: 274.52M
   • Revenue (ttm): 136.36M

   • Net Income (ttm): 48.13M
   • Shares Out: 151.67M

   • 
   • 
   • 
   • 

6. seekingalpha.com › symbol › HRTXHeron Therapeutics, Inc. (HRTX) Stock Price, Quote, News ...

   seekingalpha.com › symbol › HRTX

   4 days ago · A high-level overview of Heron Therapeutics, Inc. (HRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

7. www.morningstar.com › stocks › XNASHRTX Stock Price Quote | Morningstar

   www.morningstar.com › stocks › XNAS

   • Cached

   5 days ago · See the latest Heron Therapeutics Inc stock price (HRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

   • Current Ratio: 2.38

   • Quick Ratio: 1.76

8. www.bloomberg.com › quote › HRTX:USHRTX: Heron Therapeutics Inc Stock Price Quote - NASDAQ CM ...

   www.bloomberg.com › quote › HRTX:US

   • Cached

   1 day ago · Stock analysis for Heron Therapeutics Inc (HRTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

9. www.nasdaq.com › market-activity › stocksHeron Therapeutics, Inc. Common Stock - Nasdaq

   www.nasdaq.com › market-activity › stocks

   • Cached

   Discover real-time Heron Therapeutics, Inc. Common Stock (HRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...